MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Essential tremor(ET)"

  • 2024 International Congress

    Changes In Glucose Metabolism In Essential Tremor: Within And Beyond The Cerebello-Thalamo-Cortical Circuit

    S. Jonker, J. Dalenberg, D. Peretti, AMM. vd Stouwe, MAJ. Tijssen (Groningen, Netherlands)

    Objective: To investigate differences in brain glucose metabolism between patients with essential tremor and healthy controls using [18F]FDG PET brain imaging. Background: The pathophysiological mechanisms…
  • 2024 International Congress

    Essential3: An Innovative Multi-Study Phase 3 Program to Evaluate the Efficacy and Safety of Ulixacaltamide

    R. Able, M. Giroux, J. Zhao, H. Jacotin, M. Sniecinski, A. Samaroo, A. La Croix, A. Wyant, C. Santos, M. Souza (Boston, USA)

    Objective: An innovative, multi-study Phase 3 program to definitively assess safety and efficacy of ulixacaltamide in essential tremor (ET). Background: Phase 2 studies of ulixacaltamide,…
  • 2024 International Congress

    Is Neuropsychological Evaluation Needed to Assess DBS Candidacy in Essential Tremor?

    T. Turner, C. Cooper, F. Rodriguez-Porcel, D. Lench, V. Hinson, G. Revuelta (Charleston, USA)

    Objective: In this study we examined frequency of cognitive and psychiatric disorders identified during neuropsychological evaluation for Deep Brain Stimulation (DBS) in patients with Essential…
  • 2024 International Congress

    Effects of Loading, Tapping Performance, and Ballistic Movements on Postural Tremor Features in Patients with Essential Tremor

    D. Birreci, D. Costa, L. Angelini, A. Cannavacciuolo, M. Passaretti, A. Martini, M. de Riggi, G. Paparella, M. Bologna (Rome, Italy)

    Objective: To comprehensively evaluate the effects of loading, tapping performance, and ballistic movements on major tremor features in patients with essential tremor (ET). Background: In…
  • 2024 International Congress

    MRgFUS thalamotomy for essential tremor: Lesion location and clinical outcomes

    M. Rodriguez-Oroz, AA. Arcadi, LGQ. Gonzalez Quarante, IA. Aviles-Olmos, AMB. Bastidas, AJH. Jimenez Huete, AG. Gorospe, JG. Guridi (Pamplona, Spain)

    Objective: To examine the clinical outcomes and their relationship with patients’ baseline demographic and clinical features and lesion characteristics at 6-month follow-up in ET patients.…
  • 2023 International Congress

    Relationship between postural and kinetic tremor control with VIM-DBS in Essential Tremor

    R. Butler, M. Blumenfeld, A. Brinda, M. Bryants, D. Sullivan, S. Pandey, J. Vitek, L. Schrock, K. Gagesch, K. Domingo, T. Orcutt, J. Matsumoto, S. Cooper, M. Johnson (Minneapolis, USA)

    Objective: To provide improved understanding of the relationship between postural and kinetic tremor presentation with deep brain stimulation (DBS) in Essential Tremor (ET). Background: ET…
  • 2023 International Congress

    Subject-specific investigation of pathways underlying therapeutic outcomes of deep brain stimulation for Essential Tremor

    R. Butler, M. Blumenfeld, A. Brinda, M. Bryants, D. Sullivan, S. Pandey, T. Palnitkar, R. Patriat, J. Vitek, L. Schrock, K. Gagesch, K. Domingo, T. Orcutt, N. Harel, J. Matsumoto, S. Cooper, M. Johnson (Minneapolis, USA)

    Objective: To relate subject-specific pathway activation models of motor thalamic deep brain stimulation (DBS) to clinical outcomes in patients with Essential Tremor (ET). Background: Computational…
  • 2023 International Congress

    Double-blind, randomized, crossover clinical trial to compare VIM vs PSA deep brain stimulation in patients with disabling essential tremor. Preliminary results.

    L. Triguero-Cueva, CJ. Madrid Navarro, MJ. Perez Navarro, B. Iáñez Velasco, M. Jouma Katati, JP. Martínez Barbero, A. Mínguez-Castellanos, F. Escamilla Sevilla (Jódar, Spain)

    Objective: To compare the safety, efficacy, energy efficiency and quality of life (QoL) outcomes of bilateral PSA-DBS vs bilateral VIM-DBS in the treatment of refractory…
  • 2023 International Congress

    Patient experiences in essential tremor: mapping functional impacts to existing measures using qualitative research

    M. Gerbasi, D. Goss, J. Petrillo, M. Nejati, S. Lewis (Cambridge, USA)

    Objective: To understand patient experience in essential tremor (ET), describe meaningful concepts related to treatment benefit, and compare concepts to existing clinical outcome assessments (COAs).…
  • 2023 International Congress

    Focused ultrasound as rescue treatment of essential tremor after deep brain stimulation.

    D. Vilas, M. Tardáguila, L. Ispierto, J. Muñoz, M. Gea, A. Gonzalez, S. Jaume, G. Plans, R. Alvarez (Badalona, Spain)

    Objective: To describe a case of disabling essential tremor (ET) treated with unilateral MRI-Guided Focused Ultrasound (FUS) thalamotomy as rescue treatment after deep brain stimulation…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 50
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley